vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and FLOWERS FOODS INC (FLO). Click either name above to swap in a different company.
FLOWERS FOODS INC is the larger business by last-quarter revenue ($1.2B vs $950.5M, roughly 1.3× Astrana Health, Inc.). On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs -75.8%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs -11.6%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Flowers Foods, headquartered in Thomasville, Georgia, is a producer and marketer of packaged bakery foods in the United States. The company operates 44 bakeries across 19 states that produce a variety of products, including bread, buns, rolls, snack cakes, pastries, and tortillas. As of February 2013, Flowers Foods had grown to be the "second-largest baking company in the United States."
ASTH vs FLO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.2B |
| Net Profit | $6.6M | — |
| Gross Margin | — | — |
| Operating Margin | 1.9% | — |
| Net Margin | 0.7% | — |
| Revenue YoY | 42.9% | -75.8% |
| Net Profit YoY | 184.4% | — |
| EPS (diluted) | $0.12 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.2B | ||
| Q3 25 | $956.0M | $1.2B | ||
| Q2 25 | $654.8M | $1.6B | ||
| Q1 25 | $620.4M | — | ||
| Q4 24 | $665.2M | $1.2B | ||
| Q3 24 | $478.7M | $1.2B | ||
| Q2 24 | $486.3M | $1.6B | ||
| Q1 24 | $404.4M | — |
| Q4 25 | $6.6M | $39.5M | ||
| Q3 25 | $373.0K | $58.4M | ||
| Q2 25 | $9.4M | $53.0M | ||
| Q1 25 | $6.7M | — | ||
| Q4 24 | $-7.8M | $65.0M | ||
| Q3 24 | $16.1M | $67.0M | ||
| Q2 24 | $19.2M | $73.0M | ||
| Q1 24 | $14.8M | — |
| Q4 25 | 1.9% | 5.4% | ||
| Q3 25 | 2.0% | 7.5% | ||
| Q2 25 | 3.1% | 5.5% | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 0.1% | 7.6% | ||
| Q3 24 | 5.9% | 7.8% | ||
| Q2 24 | 6.2% | 6.4% | ||
| Q1 24 | 7.5% | — |
| Q4 25 | 0.7% | 3.2% | ||
| Q3 25 | 0.0% | 4.7% | ||
| Q2 25 | 1.4% | 3.4% | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | -1.2% | 5.5% | ||
| Q3 24 | 3.4% | 5.5% | ||
| Q2 24 | 3.9% | 4.6% | ||
| Q1 24 | 3.7% | — |
| Q4 25 | $0.12 | $0.19 | ||
| Q3 25 | $0.01 | $0.28 | ||
| Q2 25 | $0.19 | $0.25 | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-0.14 | $0.31 | ||
| Q3 24 | $0.33 | $0.32 | ||
| Q2 24 | $0.40 | $0.34 | ||
| Q1 24 | $0.31 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $12.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | — |
| Total Assets | $2.2B | $4.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $16.7M | ||
| Q3 25 | $463.4M | $11.0M | ||
| Q2 25 | $342.1M | $7.3M | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | $15.0M | ||
| Q3 24 | $350.3M | $6.9M | ||
| Q2 24 | $327.7M | $15.8M | ||
| Q1 24 | $337.3M | — |
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.0B | ||
| Q1 24 | — | — |
| Q4 25 | $779.3M | $1.4B | ||
| Q3 25 | $775.5M | $1.4B | ||
| Q2 25 | $765.5M | $1.4B | ||
| Q1 25 | $745.4M | — | ||
| Q4 24 | $712.7M | $1.4B | ||
| Q3 24 | $704.6M | $1.4B | ||
| Q2 24 | $678.9M | $1.4B | ||
| Q1 24 | $653.5M | — |
| Q4 25 | $2.2B | $4.3B | ||
| Q3 25 | $2.2B | $4.3B | ||
| Q2 25 | $1.4B | $4.3B | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.4B | $3.4B | ||
| Q3 24 | $1.3B | $3.4B | ||
| Q2 24 | $1.3B | $3.4B | ||
| Q1 24 | $1.2B | — |
| Q4 25 | — | 1.25× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.26× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.75× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $125.4M |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $54.4M | ||
| Q3 25 | $10.0M | $130.8M | ||
| Q2 25 | $90.9M | $135.6M | ||
| Q1 25 | $16.6M | — | ||
| Q4 24 | $-10.9M | $113.9M | ||
| Q3 24 | $34.0M | $63.3M | ||
| Q2 24 | $23.2M | $105.1M | ||
| Q1 24 | $6.0M | — |
| Q4 25 | $-6.0M | $30.4M | ||
| Q3 25 | $7.4M | $100.0M | ||
| Q2 25 | $89.5M | $110.1M | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | $88.6M | ||
| Q3 24 | $31.7M | $35.4M | ||
| Q2 24 | $20.4M | $71.8M | ||
| Q1 24 | $5.6M | — |
| Q4 25 | -0.6% | 2.5% | ||
| Q3 25 | 0.8% | 8.0% | ||
| Q2 25 | 13.7% | 7.1% | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | 7.4% | ||
| Q3 24 | 6.6% | 2.9% | ||
| Q2 24 | 4.2% | 4.6% | ||
| Q1 24 | 1.4% | — |
| Q4 25 | 0.3% | 2.0% | ||
| Q3 25 | 0.3% | 2.5% | ||
| Q2 25 | 0.2% | 1.6% | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | 2.1% | ||
| Q3 24 | 0.5% | 2.3% | ||
| Q2 24 | 0.6% | 2.1% | ||
| Q1 24 | 0.1% | — |
| Q4 25 | -0.44× | 1.38× | ||
| Q3 25 | 26.69× | 2.24× | ||
| Q2 25 | 9.65× | 2.56× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | 1.75× | ||
| Q3 24 | 2.11× | 0.94× | ||
| Q2 24 | 1.21× | 1.44× | ||
| Q1 24 | 0.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
FLO
Segment breakdown not available.
